CFTR and cystic fibrosis: Second, the lack of detailed clinical data, including pulmonary function tests and imaging diagnostics, such as chest X-rays or CT scans, as well as the molecular profiles such as CFTR mutation types, and detailed genotype information, limits the ability to fully characterize disease severity and treatment response across the spectrum of CF genotypes.